News
COVID-19 vaccine study focuses on young and immunosuppressed
Immunosuppressed transplant recipients between the ages of 12 to 17-years-old have been added to the MELODY study population, which analyses how well additional doses of the COVID-19 vaccine protects immunosuppressed people.